Study Reveals Multiple Myeloma Treatment Disparities Between Caucasian, African-American Patients
Celgene Corporation recently presented a study comparing overall survival, treatment patterns, and healthcare costs between Caucasian (white-skinned) and African-American Medicare beneficiaries who were diagnosed with multiple myeloma, revealing there are discrepancies in treatment initiation between the two patient populations and discussing the impact of these inequalities on clinical outcomes. The study was presented at…